1

Biotechnology Equity Analyst Jobs (NOW HIRING)

Analyze global equity markets, industry dynamics, and macroeconomic trends to inform business ... Incorporate domain knowledge-particularly in healthcare, biotechnology, or medical research-into ...

Analyze global equity markets, industry dynamics, and macroeconomic trends to inform business ... Incorporate domain knowledge-particularly in healthcare, biotechnology, or medical research-into ...

... Biotechnology equity research team. The position is located in New York City. As a Research ... Strong writing and analytical skills. Associates are responsible for writing and producing equity ...

next page

Showing results 1-20

Biotechnology Equity Analyst information

See salary details

$40K

$92K

$142.5K

How much do biotechnology equity analyst jobs pay per year?

As of Jul 3, 2026, the average yearly pay for biotechnology equity analyst in the United States is $91,965.00, according to ZipRecruiter salary data. Most workers in this role earn between $62,000.00 and $115,000.00 per year, depending on experience, location, and employer.

What is the highest paid job in biotechnology?

In biotechnology, executive roles such as Chief Scientific Officer (CSO) or Chief Executive Officer (CEO) tend to be the highest paid, often earning six- or seven-figure salaries with additional bonuses and stock options. Senior roles requiring extensive experience, leadership skills, and advanced degrees typically command the highest compensation in the industry.

What are the key skills and qualifications needed to thrive in the Biotechnology Equity Analyst position, and why are they important?

To thrive as a Biotechnology Equity Analyst, you need a strong background in finance, life sciences, and analytical research, typically supported by degrees in finance or a science-related field. Familiarity with financial modeling tools, Bloomberg Terminal, and relevant certifications such as the CFA is highly beneficial. Excellent communication, attention to detail, and intellectual curiosity help professionals excel in this role. These skills are vital for accurately assessing biotechnology companies, creating insightful reports, and supporting sound investment decisions in a dynamic, specialized sector.

What are some typical challenges Biotechnology Equity Analysts face in their daily work?

One common challenge for Biotechnology Equity Analysts is staying current with rapid scientific advancements while also navigating complex financial markets. Analysts frequently assess clinical data, regulatory outcomes, and patent landscapes, which require both technical understanding and strong analytical skills. Additionally, they must communicate their findings clearly to both technical and non-technical stakeholders, including portfolio managers and clients. Balancing the fast pace of breaking news in biotech with thorough due diligence is critical to success in this field.

What is a Biotechnology Equity Analyst job?

A Biotechnology Equity Analyst evaluates publicly traded biotech companies to provide investment recommendations. They analyze financial statements, clinical trial data, regulatory developments, and industry trends to assess a company's growth potential and risks. Analysts often work for investment firms, hedge funds, or asset management companies, producing reports and advising investors. Strong expertise in biotechnology, finance, and market dynamics is essential for this role.

Will AI replace biotechnologists?

AI can assist biotechnologists by automating data analysis, optimizing experiments, and improving research efficiency, but it is unlikely to fully replace the expertise, critical thinking, and hands-on skills required in biotechnology roles. Biotechnologists will continue to be essential for designing experiments, interpreting complex biological data, and ensuring ethical standards. Proficiency in laboratory techniques and familiarity with AI tools are valuable for this profession.

How much does a biotech equity analyst make?

A biotech equity analyst typically earns between $70,000 and $150,000 annually, depending on experience, location, and the size of the firm. Senior analysts or those in major financial hubs can earn higher salaries, often supplemented with bonuses and stock options.

How to break into biotech equity research?

Breaking into biotech equity research typically requires a strong background in finance, biology, or related fields, along with analytical skills and familiarity with financial modeling and valuation techniques. Relevant experience through internships, a finance or science degree, and certifications like the CFA can improve prospects. Networking within the industry and staying informed about biotech developments are also important for entry.
More about Biotechnology Equity Analyst jobs
What cities are hiring for Biotechnology Equity Analyst jobs? Cities with the most Biotechnology Equity Analyst job openings:
What states have the most Biotechnology Equity Analyst jobs? States with the most job openings for Biotechnology Equity Analyst jobs include:
What job categories do people searching Biotechnology Equity Analyst jobs look for? The top searched job categories for Biotechnology Equity Analyst jobs are:
Infographic showing various Biotechnology Equity Analyst job openings in the United States as of June 2026, with employment types broken down into 100% Full Time. Highlights an 67% In-person, and 33% Remote job distribution, with an average salary of $91,965 per year, or $44.2 per hour.
Research Associate - Biotechnology

Research Associate - Biotechnology

Oppenheimer

New York, NY

$100K - $150K/yr

Other

Posted 23 hours ago


Job description

Who We Are:

Oppenheimer & Co. Inc. (Oppenheimer) is a leading middle-market investment bank and full-service broker-dealer. With roots tracing back to 1881, the Company is engaged in a broad range of activities in the financial services industry, including retail securities brokerage, institutional sales and trading, investment banking (both corporate and public finance), equity & fixed income research, market making, trust services and investment advisory and asset management services.

Job Description:

Oppenheimer & Co. Inc., a leading mid-tier investment bank, is currently seeking a Research Associate to join our Biotechnology equity research team. The position is located in New York City.

As a Research Associate, you will work directly with the Senior Research Analyst on many aspects of the research process including: writing investment-driven research reports, developing and fielding industry surveys, attending medical and scientific conferences, building and maintaining financial models, performing fundamental analysis and due diligence on a variety of therapeutics companies, and undertaking a wide array of industry analyses and competitive assessments. The associate will have broad exposure to company managements and investor events, and will interface with key opinion leaders, institutional investor clients, and internal sales force and trading personnel.

A strong candidate is independently motivated, analytically minded, and intellectually curious; possesses at least some experience with financial modeling and exposure to the equity markets; and, has a passion for life sciences investing.

Attention to detail, a strong work ethic, effective oral and written communication skills, and an excellent academic record are required. An advanced degree (e.g. MS, MBA, MD, and/or PhD) would be a plus, but is not required.

We look for people who possess the following characteristics:

  • Exceptional academic background.
  • A thorough understanding of the investment process and the ability to perform deep primary research.
  • Excellent quantitative and financial modeling skills. Associates are responsible for building and maintaining company financial models and for organizing and updating industry data.
  • Strong writing skills. Associates are responsible for authoring equity research reports, company initiations, industry reports, and marketing presentationssometimes under tight time constraints.
  • Responsiveness, professionalism, and the ability to manage priorities to meet deadlines.
  • Experience in biotechnology equity research, drug development, or related field preferred.
  • Proficiency in Microsoft Office; FactSet, Symphony, Bloomberg would be a bonus.
  • (FINRA Registrations: SIE, Series 7/63/86/87) preferred.

Compensation:

For job postings in New York City, Oppenheimer is required by law to include a reasonable estimate of the salary range for this role. This salary range is specific to the City of New York and takes into account the wide range of factors that are considered in making salary decisions including but not limited to your skills, qualifications, experience, licensure and certifications, and other business and organizational needs. A reasonable estimate of the current base salary range is $100,000.00 - $150,000.00 at the time of this posting. Also, certain positions are eligible for additional forms of compensation such as discretionary bonus.